Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the eight research firms that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating and six have assigned a buy rating to the company. The average 12-month price […]